|
16 Companies |
|
21 Products |
|
21 Products |
|
17 Mechanisms of Action |
|
0 Trials |
|
174 News |
|
| «1234» |
- clomifene citrate / Generic mfg.
Trial primary completion date: DNAFRAG: The Predictive Value of the Sperm Chromatin Dispersion Test, Halosperm (clinicaltrials.gov) - Jul 8, 2015
P=N/A, N=100, Recruiting, Sponsor: University Hospital, Ghent
Trial primary completion date: Jun 2015 --> Dec 2015
- Enrollment change, Trial withdrawal: The Paleolithic Diet and Male Factor Infertility (clinicaltrials.gov) - Jun 23, 2015
P=N/A, N=0, Withdrawn, Sponsor: HaEmek Medical Center, Israel
Trial primary completion date: Jun 2015 --> Dec 2015 N=20 --> 0 | Not yet recruiting --> Withdrawn
- Trial primary completion date: Choline Dehydrogenase and Sperm Function: Effects of Betaine (clinicaltrials.gov) - Jun 16, 2015
P1, N=15, Recruiting, Sponsor: University of North Carolina, Chapel Hill
N=20 --> 0 | Not yet recruiting --> Withdrawn Trial primary completion date: Feb 2015 --> Feb 2016
- Trial completion, Preclinical: inSIGHT: SIGnificance of Routine Hysteroscopy Prior to a First 'in Vitro Fertilization'(IVF) Treatment Cycle (clinicaltrials.gov) - Jun 4, 2015
P4, N=750, Completed, Sponsor: UMC Utrecht
Trial primary completion date: Feb 2015 --> Feb 2016 Active, not recruiting --> Completed
- Ovidrel (choriogonadotropin alfa) / EMD Serono
Enrollment open, Phase classification, Enrollment change, Trial primary completion date: The Effect of a Dual Trigger on Intracytoplasmic Sperm Injection (ICSI) Reproductive Outcomes (clinicaltrials.gov) - May 27, 2015
P=N/A, N=800, Recruiting, Sponsor: Antalya IVF
Active, not recruiting --> Completed Terminated --> Recruiting | Phase classification: P4 --> PN/A | N=400 --> 800 | Trial primary completion date: Mar 2015 --> Jun 2016
- Preclinical, Enrollment change, Trial withdrawal, Trial primary completion date: Sibling Oocyte Study of Medium for In Vitro Fertilization/Intracytoplasmic Sperm Injection (IVF/ICSI) With no Human Serum Albumine (clinicaltrials.gov) - May 20, 2015
P2, N=0, Withdrawn, Sponsor: Sykehuset Telemark
Terminated --> Recruiting | Phase classification: P4 --> PN/A | N=400 --> 800 | Trial primary completion date: Mar 2015 --> Jun 2016 N=150 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Dec 2011 --> Jan 2014
- Enrollment change, Trial withdrawal, Trial primary completion date: Fertilizations With Immotile Sperm: Pentoxyphylline Activation Alone, or With Chemical Oocyte Activation (clinicaltrials.gov) - May 6, 2015
P4, N=0, Withdrawn, Sponsor: Rambam Health Care Campus
N=150 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Dec 2011 --> Jan 2014 N=50 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Mar 2016 --> May 2015
- Enrollment change: Metasperme: Metabolic Syndrome and Male Infertility (clinicaltrials.gov) - Apr 21, 2015
P=N/A, N=170, Recruiting, Sponsor: Assistance Publique - Hôpitaux de Paris
N=50 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Mar 2016 --> May 2015 N=520 --> 170
- Enrollment change, Trial primary completion date: Impact of Sperm DNA Integrity on Artificial Reproductive Treatment (ART) (clinicaltrials.gov) - Apr 21, 2015
P=N/A, N=8, Terminated, Sponsor: North Shore Long Island Jewish Health System
N=520 --> 170 N=1000 --> 8 | Trial primary completion date: Dec 2009 --> Dec 2008
- Enrollment closed, Surgery, Bariatric surgery: BARIASPERM: Bariatric Surgery and Sperm Quality (clinicaltrials.gov) - Apr 21, 2015
P=N/A, N=46, Active, not recruiting, Sponsor: Assistance Publique - Hôpitaux de Paris
N=1000 --> 8 | Trial primary completion date: Dec 2009 --> Dec 2008 Recruiting --> Active, not recruiting
- Trial initiation date: MACs-ESD: Does DNA Sperm Fragmentation Affects Embryo Morphokinetic? (clinicaltrials.gov) - Apr 19, 2015
P=N/A, N=60, Not yet recruiting, Sponsor: IVI Madrid
Recruiting --> Active, not recruiting Initiation date: Dec 2014 --> Dec 2015
- Trial completion, Trial primary completion date: A Two-part Trial Assessing the Effects of 7?-methyl-19-nortestosterone (MENT) on Blood Pressure in Normal Men: an Open-label Pilot Study Followed by a Randomized, Double-blind, Placebo-controlled Study (clinicaltrials.gov) - Apr 17, 2015
P1, N=68, Completed, Sponsor: Population Council
Initiation date: Dec 2014 --> Dec 2015 Active, not recruiting --> Completed | Trial primary completion date: Jun 2012 --> Mar 2014
- | cabergoline / Generic mfg.
Enrollment closed, Trial primary completion date: Cabergoline and Coasting to Prevent OHSS (clinicaltrials.gov) - Apr 3, 2015
P3, N=300, Active, not recruiting, Sponsor: Cairo University
Active, not recruiting --> Completed | Trial primary completion date: Jun 2012 --> Mar 2014 Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2015 --> Jul 2015
- enoxaparin sodium / Generic mfg.
Trial completion, Enrollment closed: Local Uterine Application of Low Molecular Weight Heparin (LMWH) in Intra-cytoplasmic Sperm Injection (ICSI) (clinicaltrials.gov) - Mar 24, 2015
P1, N=40, Completed, Sponsor: The Egyptian IVF-ET Center
Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2015 --> Jul 2015 Recruiting --> Completed
- Trial completion, Enrollment change: Sperm Banking Among Adolescents Newly Diagnosed With Cancer: Development of a Profiling and Referral Tool (clinicaltrials.gov) - Mar 10, 2015
P=N/A, N=282, Completed, Sponsor: St. Jude Children's Research Hospital
Recruiting --> Completed Active, not recruiting --> Completed | N=618 --> 282
- Preclinical, Enrollment change: Human Sperm Binding to Transgenic Mouse Eggs (clinicaltrials.gov) - Mar 7, 2015
P=N/A, N=40, Completed, Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Active, not recruiting --> Completed | N=618 --> 282 N=13 --> 40
- Trial completion: Prospective Observational Correlation of Sperm Assay Results With Blastocyst Formation (clinicaltrials.gov) - Mar 7, 2015
P=N/A, N=40, Completed, Sponsor: Bruce Shapiro M.D.
N=13 --> 40 Not yet recruiting --> Completed
- Trial completion, Preclinical, Trial primary completion date: Role of Follicular Output Rate in the Prediction of in Vitro Fertilization and Intracytoplasmic Sperm Injection in Women With Unexplained Infertility (clinicaltrials.gov) - Feb 19, 2015
P=N/A, N=300, Completed, Sponsor: Cairo University
Not yet recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Dec 2015 --> Feb 2015
- Preclinical, Trial primary completion date: Role of Follicular Output Rate in the Prediction of in Vitro Fertilization and Intracytoplasmic Sperm Injection in Women With Unexplained Infertility (clinicaltrials.gov) - Feb 3, 2015
P=N/A, N=300, Recruiting, Sponsor: Cairo University
Recruiting --> Completed | Trial primary completion date: Dec 2015 --> Feb 2015 Trial primary completion date: Dec 2014 --> Dec 2015
- Suprefact (buserelin acetate) / Sanofi
Preclinical, Trial primary completion date: Age Versus Ovarian Reserve Markers Based Therapy in IVF (IVF)/Intracytoplasmic Sperm Injection (ICSI) Cycles (clinicaltrials.gov) - Jan 28, 2015
P4, N=360, Recruiting, Sponsor: Andros Day Surgery Clinic
Trial primary completion date: Dec 2014 --> Dec 2015 Trial primary completion date: Oct 2014 --> Mar 2015
- | cabergoline / Generic mfg.
Enrollment change, Trial primary completion date: Cabergoline and Coasting to Prevent OHSS (clinicaltrials.gov) - Jan 20, 2015
P3, N=300, Recruiting, Sponsor: Cairo University
Trial primary completion date: Oct 2014 --> Mar 2015 N=200 --> 300 | Trial primary completion date: Jun 2014 --> Mar 2015
- Trial primary completion date: Vitamin D Supplementation and Male Infertility: The CBG-study a Randomized Clinical Trial (clinicaltrials.gov) - Jan 2, 2015
P4, N=300, Active, not recruiting, Sponsor: Rigshospitalet, Denmark
N=200 --> 300 | Trial primary completion date: Jun 2014 --> Mar 2015 Trial primary completion date: Mar 2015 --> Dec 2014
- enoxaparin sodium / Generic mfg.
New P1 trial: Local Uterine Application of Low Molecular Weight Heparin (LMWH) in Intra-cytoplasmic Sperm Injection (ICSI) (clinicaltrials.gov) - Dec 29, 2014
P1, N=40, Recruiting, Sponsor: The Egyptian IVF-ET Center
- Enrollment change, Trial termination: IMSI in Couples With Previous Implantation Failures (clinicaltrials.gov) - Nov 18, 2014
P=N/A, N=25, Terminated, Sponsor: Sapientiae Institute
Trial primary completion date: Mar 2015 --> Dec 2014 N=186 --> 25 | Recruiting --> Terminated; broken equipment
- Enrollment change, Trial withdrawal: The Benefits of Intracytoplasmic Morphologically Selected Sperm Injection (IMSI) in Couples With Unexplained Infertility (clinicaltrials.gov) - Nov 18, 2014
P=N/A, N=0, Withdrawn, Sponsor: Sapientiae Institute
N=186 --> 25 | Recruiting --> Terminated; broken equipment N=72 --> 0 | Not yet recruiting --> Withdrawn
- Trial completion, Trial primary completion date: Motile Sperm Organelle Morphology Examination (MSOME) Influence on Intracytoplasmic Sperm Injection (ICSI) Outcomes in Infertile Couples (clinicaltrials.gov) - Nov 18, 2014
P=N/A, N=72, Completed, Sponsor: Sapientiae Institute
N=72 --> 0 | Not yet recruiting --> Withdrawn Recruiting --> Completed | Trial primary completion date: Jan 2013 --> Dec 2013
- Trial completion, Trial primary completion date: Influence of Sperm With Large Nuclear Vacuole on ICSI Outcomes (clinicaltrials.gov) - Nov 18, 2014
P=N/A, N=200, Completed, Sponsor: Sapientiae Institute
Recruiting --> Completed | Trial primary completion date: Jan 2013 --> Dec 2013 Recruiting --> Completed | Trial primary completion date: Feb 2013 --> Jan 2014
- Enrollment closed, Trial primary completion date: Vitamin D Supplementation and Male Infertility: The CBG-study a Randomized Clinical Trial (clinicaltrials.gov) - Nov 6, 2014
P4, N=300, Active, not recruiting, Sponsor: Rigshospitalet, Denmark
Recruiting --> Completed | Trial primary completion date: Feb 2013 --> Jan 2014 Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2014 --> Mar 2015
- Enrollment open: Fertilizations With Immotile Sperm: Pentoxyphylline Activation Alone, or With Chemical Oocyte Activation (clinicaltrials.gov) - Nov 5, 2014
P4, N=50, Recruiting, Sponsor: Rambam Health Care Campus
Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2014 --> Mar 2015 Not yet recruiting --> Recruiting
- Preclinical: Correlating In Vitro Fertilization Outcomes After Euploid Blastocyst Transfer With Sperm DNA Fragmentation (clinicaltrials.gov) - Oct 20, 2014
P=N/A, N=600, Enrolling by invitation, Sponsor: Reproductive Medicine Associates of New Jersey
- Trial primary completion date: Application of MACS and Time-lapse Technology in Good-prognosis Patients (clinicaltrials.gov) - Oct 11, 2014
P=N/A, N=200, Recruiting, Sponsor: IVI Sevilla
Not yet recruiting --> Recruiting Trial primary completion date: May 2014 --> May 2015
- Trial primary completion date: FOLFIV: Impact of Folates in the Care of the Male Infertility (clinicaltrials.gov) - Oct 11, 2014
P3, N=368, Recruiting, Sponsor: Assistance Publique - H
Trial primary completion date: May 2014 --> May 2015 Trial primary completion date: Dec 2014 --> Jun 2016
- Trial completion, Enrollment change: Effects of Plant Extracts on Semen Quality (clinicaltrials.gov) - Oct 10, 2014
P=N/A, N=70, Completed, Sponsor: Horsens Hospital
Trial primary completion date: Dec 2014 --> Jun 2016 Active, not recruiting --> Completed | N=100 --> 70
- ||||||| Androxal (enclomifene) / AbbVie
Trial completion: A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62% (clinicaltrials.gov) - Oct 2, 2014
P3, N=120, Completed, Sponsor: Repros Therapeutics Inc.
Active, not recruiting --> Completed | N=100 --> 70 Active, not recruiting --> Completed
- ||||||| Androxal (enclomifene) / AbbVie
Trial completion: A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62% (clinicaltrials.gov) - Oct 2, 2014
P3, N=120, Completed, Sponsor: Repros Therapeutics Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- temozolomide / Generic mfg.
Trial completion: Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors (clinicaltrials.gov) - Sep 30, 2014
P=N/A, N=16, Completed, Sponsor: Comprehensive Cancer Center of Wake Forest University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||| Clinical data, Trial completion, Enrollment change: ESCORT: An Observational Study to Evaluate Efficacy, Safety and Clinical Outcomes of Currently Used Pharmaceutical Therapies for Controlled Ovarian Stimulation in Assisted Reproductive Techniques (clinicaltrials.gov) - Sep 15, 2014
P=N/A, N=10103, Completed, Sponsor: Merck KGaA
Active, not recruiting --> Completed Recruiting --> Completed | N=8100 --> 10103
- New P2 trial, Preclinical: A Clinical Trial to Study the Safety and Efficacy of Chandrakanthi Choornam in Patients With Low Sperm Count (clinicaltrials.gov) - Sep 9, 2014
P2, N=40, Completed, Sponsor: Tamil Nadu Dr.M.G.R.Medical University
- clomifene citrate / Generic mfg.
Clinical: DNAFRAG: The Predictive Value of the Sperm Chromatin Dispersion Test, Halosperm®, Before and After Sperm Preparation for Clinical Pregnancy in Cases of Unexplained Infertility Treated With Intra-uterine Insemination (First Cycle) and Ovulation Induction With Clomiphene Citrate. (clinicaltrials.gov) - Sep 9, 2014
P=N/A, N=100, Recruiting, Sponsor: University Hospital, Ghent
- Clinical: Impact of Exclusive Enteral Nutrition Therapy on Sperm Quality of Patients With Crohn's Disease (clinicaltrials.gov) - Sep 8, 2014
P=N/A, N=12, Completed, Sponsor: Jinling Hospital, China
- Clinical: Effects of PGS in Infertile Female Patients With RPL (clinicaltrials.gov) - Aug 22, 2014
P=N/A, N=240, Recruiting, Sponsor: ShangHai Ji Ai Genetics & IVF Institute
- Enrollment change, Trial primary completion date: IMSI in Couples With Previous Implantation Failures (clinicaltrials.gov) - Aug 6, 2014
P=N/A, N=186, Recruiting, Sponsor: Sapientiae Institute
Recruiting --> Completed | N=8100 --> 10103 N=386 --> 186 | Trial primary completion date: Jun 2015 --> Oct 2014
- Trial completion: MACS: Methods for Objective Selection of Competent Sperm (clinicaltrials.gov) - Aug 4, 2014
P=N/A, N=275, Completed, Sponsor: Instituto Valenciano de Infertilidad, IVI VALENCIA
N=386 --> 186 | Trial primary completion date: Jun 2015 --> Oct 2014 Recruiting --> Completed
- Preclinical, Trial primary completion date: The ERA Test as a Diagnostic Guide for Personalized Embryo Transfer (clinicaltrials.gov) - Jul 12, 2014
P=N/A, N=2442, Recruiting, Sponsor: Igenomix
Recruiting --> Completed Trial primary completion date: Oct 2014 --> Oct 2015
- Preclinical: Role of Follicular Output Rate in the Prediction of in Vitro Fertilization and Intracytoplasmic Sperm Injection in Women With Unexplained Infertility (clinicaltrials.gov) - Jun 2, 2014
P=N/A, N=300, Recruiting, Sponsor: Cairo University
- Utrogestan (progesterone) / Besins Healthcare
Preclinical: Implantation Enhancement by Elective Cryopreservation of All Viable Embryos (clinicaltrials.gov) - May 26, 2014
P=N/A, N=212, Recruiting, Sponsor: Universitair Ziekenhuis Brussel
- ||||| Androxal (enclomifene) / AbbVie
Enrollment closed: A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62% (clinicaltrials.gov) - May 20, 2014
P3, N=120, Active, not recruiting, Sponsor: Repros Therapeutics Inc.
Trial primary completion date: Oct 2014 --> Oct 2015 Recruiting --> Active, not recruiting
- anastrozole / Generic mfg.
Trial termination: Aromatase Inhibitors in the Treatment of Male Infertility (clinicaltrials.gov) - May 19, 2014
P3, N=17, Terminated, Sponsor: University of Utah
Recruiting --> Active, not recruiting Recruiting --> Terminated; Not able meet target enrollment.
- anastrozole / Generic mfg.
Enrollment change: Aromatase Inhibitors in the Treatment of Male Infertility (clinicaltrials.gov) - May 19, 2014
P3, N=17, Terminated, Sponsor: University of Utah
Recruiting --> Terminated; Not able meet target enrollment. N=50 --> 17
- New P1 trial: Choline Dehydrogenase and Sperm Function: Effects of Betaine (clinicaltrials.gov) - Apr 22, 2014
P1, N=15, Recruiting, Sponsor: University of North Carolina, Chapel Hill